Research graph
References from Efficacy and safety of risk-stratified chemotherapy with azacitidine for children with myeloid leukaemia with Down syndrome: protocol for a multicentre phase II trial (JCCG AML-D24). Local targets link to admitted publications; unresolved targets remain external evidence.
10.1182/blood-2017-01-764324
10.1182/blood-2017-01-764324 · External reference
10.1182/blood-2017-01-765057
10.1182/blood-2017-01-765057 · External reference
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome
10.1038/s41375-021-01157-w · 2021 · External reference
10.1182/blood-2012-03-414755
10.1182/blood-2012-03-414755 · External reference
Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome
10.1182/bloodadvances.2022009381 · 2023 · External reference
10.1200/jco.2007.12.3687
10.1200/jco.2007.12.3687 · External reference
10.1002/cncr.27484
10.1002/cncr.27484 · External reference
10.3324/haematol.2013.089425
10.3324/haematol.2013.089425 · External reference
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial
10.1182/blood.2021012206 · 2021 · External reference
Prognostic factors for myeloid leukemia in Down syndrome: Results from the Japan Children’s Cancer Group studies AML-D05 and AML-D11
2024 · External reference
10.1200/jco.2007.13.2209
10.1200/jco.2007.13.2209 · External reference
Clinical and biological aspects of myeloid leukemia in Down syndrome
10.1038/s41375-021-01414-y · 2021 · External reference
10.1038/ng.2759
10.1038/ng.2759 · External reference
10.1182/blood.2023022247
10.1182/blood.2023022247 · External reference
Antileukemic effect of azacitidine, a DNA methyltransferase inhibitor, on cell lines of myeloid leukemia associated with Down syndrome
10.1016/j.exphem.2024.104179 · 2024 · External reference
Effective response to azacitidine in a child with a second relapse of myeloid leukemia associated with Down syndrome after bone marrow transplantation
10.1002/pbc.27414 · 2018 · External reference
Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan
10.1002/pbc.31244 · 2024 · External reference
Sample size calculations for single-arm survival studies using transformations of the Kaplan-Meier estimator
10.1002/pst.2090 · 2021 · External reference
